enVVeno Medical Corporation
NASDAQ:NVNO
5.19 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -23.516 | -24.669 | -16.528 | -9.135 | -7.625 | -13.043 | -7.791 | -3.387 | -1.604 | -0.001 |
| Depreciation & Amortization
| 0.546 | 0.525 | 0.453 | 0.384 | 0.397 | 0.133 | 0.139 | 0.151 | 0.125 | 0 |
| Deferred Income Tax
| 0.221 | 0 | -0.313 | -0.184 | 0.589 | -1.353 | -0.231 | 0.871 | 0 | 0 |
| Stock Based Compensation
| 5.196 | 8.994 | 5.999 | 0.881 | 0.942 | 1.922 | 0.878 | 1.51 | 0 | 0 |
| Change In Working Capital
| -0.616 | -0.13 | -1.145 | 0.666 | 0.067 | -0.578 | 1.093 | 0.269 | -0.541 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0.032 | 0.003 | -0.012 | 0.309 | 0.025 | -0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -0.217 | 0.091 | -0.213 | 0.172 | -0 |
| Accounts Payables
| -0.221 | 0.088 | -0.833 | 0.169 | 0.144 | -0.294 | 0.545 | -0.076 | -0.084 | 0 |
| Other Working Capital
| -0.395 | -0.218 | -0.312 | 0.497 | -0.109 | -0.07 | 0.468 | 0.25 | -0.654 | 0 |
| Other Non Cash Items
| -0.689 | -0.339 | -0.313 | -0.289 | -0.265 | 6.563 | 1.71 | -2.499 | -0 | 0.001 |
| Operating Cash Flow
| -18.858 | -15.619 | -11.846 | -7.677 | -5.896 | -6.356 | -4.202 | -3.085 | -2.019 | 0 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.033 | -0.115 | -0.368 | -0.18 | -0.364 | -0.012 | -0.011 | -0.374 | -0.003 | -0 |
| Acquisitions Net
| 0.008 | 0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -56.52 | -48.127 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 48.685 | 13.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.008 | -0.034 | 0 | 0 | 0 | 0 | 0.176 | -0.332 | -0.075 | 0 |
| Investing Cash Flow
| -7.868 | -34.554 | -0.368 | -0.18 | -0.364 | -0.012 | 0.165 | -0.705 | -0.078 | -0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | -0.313 | 0 | -1.246 | -0.175 | -0.187 | -0.612 | 0 |
| Common Stock Issued
| 25.791 | 0 | 57.607 | 10.418 | 5.637 | 7.657 | 1.082 | 2.16 | 1.871 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 25.791 | 0 | 0.058 | 4.969 | 0.006 | 2.62 | 4.233 | 2.448 | 4.236 | -0 |
| Financing Cash Flow
| 25.791 | 0 | 57.607 | 15.075 | 5.637 | 9.031 | 4.058 | 2.261 | 3.624 | -0 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.935 | -50.173 | 45.393 | 7.217 | -0.623 | 2.663 | 0.021 | -1.529 | 1.527 | 0 |
| Cash At End Of Period
| 3.62 | 4.555 | 54.728 | 9.335 | 2.117 | 2.741 | 0.078 | 0.057 | 1.585 | 0 |